US In Vitro Fertilization (IVF) Service Market Report 2023 to 2030

US In Vitro Fertilization (IVF) Service Market Analysis

$ 3999

The US In Vitro Fertilization (IVF) Service Market was valued at $9429 Mn in 2023 and is predicted to grow at a CAGR of 5.42% from 2023 to 2030, to $13643.53 Mn by 2030. The key drivers of this industry include rising infertility rates, increasing disposable income, and technological advancements. The industry is primarily dominated by players such as CCRM Fertility, IVIRMA, ELITE IVF, and Boston IVF among others

ID: IN10USHS011 CATEGORY: Healthcare Services GEOGRAPHY: US AUTHOR: Aashwi Mehta

Buy Now

US In Vitro Fertilization (IVF) Service Market Executive Summary

The US In Vitro Fertilization (IVF) Service Market was valued at $9429 Mn in 2023 and is predicted to grow at a CAGR of 5.42% from 2023 to 2030, to $13643.53 Mn by 2030.

In vitro fertilization (IVF) is a widely utilized assisted reproductive technology (ART) that helps individuals and couples overcome infertility challenges. This intricate procedure combines medications and surgical techniques to enable fertilization and implantation of embryos. The IVF process includes stimulating the ovaries to produce multiple eggs, retrieving these eggs, fertilizing them with sperm in a laboratory, culturing the resulting embryos, and then transferring one or more embryos into the uterus to achieve pregnancy. IVF is recommended for various reasons, including infertility issues, advanced maternal age, genetic concerns, and for same-sex couples or single parents. While IVF can significantly increase the chances of conception, success rates depend on factors such as the woman’s age and the underlying cause of infertility, and multiple cycles may be needed.

In 2022, the number of babies born via IVF rose to 91,771 from 89,208 in 2021, accounting for 2.5% of all births in the US. Additionally, egg-freezing cycles grew to 29,803, up from 24,560 in 2021. The market is driven by significant factors like rising infertility rates, increasing disposable income, and technological advancements. However, ethical and moral concerns, potential health risks, and emotional and physical toll restrict the growth and potential of the market.

Prominent players in this field include CCRM Fertility, IVIRMA, ELITE IVF, and Boston IVF among others.

US In Vitro Fertilization (IVF) Service Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Infertility Rates: The high rates of infertility—affecting about 10% of women and 9% of men, with 8.5% of married women and 19.4% of childless women facing infertility—boosts demand for IVF services. This widespread issue drives market growth as individuals seeks solutions to achieve their family-building goals.

Increasing Disposable Income: Rising disposable incomes allow more couples to cover the high costs of IVF treatments. This financial flexibility leads to greater access to assisted reproductive technologies, boosting demand for IVF services as more individuals can afford to pursue solutions to their fertility challenges.

Technological Advancements: Advancements in IVF technology, including enhanced embryo culture methods, genetic screening, and cryopreservation techniques, draw more patients to IVF services. These innovations offer more effective treatments, driving growth in the IVF market as individuals seek the latest and most reliable fertility solutions.

Market Restraints

Ethical and Moral Concerns: Ethical concerns related to embryo disposal, genetic screening, and the use of donor gametes may discourage some individuals from seeking IVF treatments. These moral debates can create hesitation and reluctance, acting as a restraint on the IVF service market by limiting the number of potential patients who are willing to undergo these procedures.

Potential Health Risk: Worries about health risks from IVF procedures, including ovarian hyperstimulation syndrome and the possibility of multiple pregnancies, can make potential patients hesitant to pursue treatment. These concerns act as a market restraint by discouraging individuals from choosing IVF due to fear of potential complications and adverse effects.

Emotional and Physical Toll: The IVF process can be both physically strenuous and emotionally challenging for couples. This intense physical and emotional strain can deter some individuals from undergoing treatment, serving as a market restraint by limiting the number of people willing to endure the demanding aspects of the IVF journey.

Regulatory Landscape and Reimbursement Scenario

At the federal level, various laws and agencies oversee assisted reproductive technologies (ART). The Fertility Clinic Success Rate and Certification Act (FCSRCA) requires fertility clinics to report their success rates to the Centers for Disease Control and Prevention (CDC). The CDC is responsible for monitoring ART cycle data and laboratory certifications. Additionally, the Food and Drug Administration (FDA) regulates the drugs, devices, and donor tissues used in ART procedures, while the Clinical Laboratory Improvement Act (CLIA) sets standards for laboratory practices. Reimbursement for IVF services in the U.S. can vary widely depending on insurance coverage, the provider, and the specific treatment plans.

Competitive Landscape

Key Players

Here are some of the major key players in the US In Vitro Fertilization (IVF) Service Market:

CCRM Fertility
IVIRMA
ELITE IVF
Boston IVF
San Diego Fertility Center
Pacific Fertility Center Los Angeles
Aspire Fertility
Pacific Fertility Center
Shady Grove Fertility
New Hope Fertility Center

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US In Vitro Fertilization (IVF) Service Market Segmentation

By Cycle Type

Fresh IVF Cycles
Thawed IVF Cycles
Donor Egg/Sperm IVF Cycles

By End Users

Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.